Discontinuation report PROCTOSEDYL

Last updated on 2024-02-23 History
Report ID 220351
Drug Identification Number 02223252
Brand name PROCTOSEDYL
Common or Proper name hydrocortisone - framycetin - dibucaine - esculin
Company Name APTALIS PHARMA CANADA ULC
Market Status MARKETED
Active Ingredient(s) ESCULIN FRAMYCETIN SULFATE DIBUCAINE HYDROCHLORIDE HYDROCORTISONE
Strength(s) 1% 1% 0.5% 0.5%
Dosage form(s) OINTMENT
Route of administration RECTAL RECTAL
Packaging size 15G and 30 G tube
ATC code C05AA
ATC description AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
Reason for discontinuation Business reasons
Anticipated discontinuation date 2024-06-30
Actual discontinuation date
Remaining supply date 2024-06-30
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply 30 G inventory is expected to deplete by May/June 2024.
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2024-02-23 English Compare
v2 2024-02-23 French Compare
v3 2024-02-23 English Compare
v4 2024-02-23 French Compare
v5 2024-02-23 English Compare
v6 2024-02-23 French Compare

Showing 1 to 6 of 6